Oral semaglutide should be considered as second-line therapy after metformin, particularly when weight is an issue and possibly in those at higher cardiovascular risk
People then realized these medications do more than just treat diabetes
Patients randomized to exenatide started on a dose of 5 mcg twice-daily for 4 weeks and then were escalated to 10 mcg twice daily
Fang Y, McGrail DJ, Sun C, Labrie M, Chen X, Zhang D, et al
W badaniach przedklinicznych wykazano te neuroprotekcyjne waciwoci agonistw GLP-1: redukcj procesw zapalnych w OUN, promowanie neurogenezy i popraw plastycznoci synaptycznej (Frontiers | GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects) (Frontiers | GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects)
No dejes que la mala salud limite tu vida